Two kaurane diterpenes, namely cafestol (1) and kahweol (2), were isolated from hydrolyzed fraction of the fixed oil of Ethiopian Coffea arabica unroasted beans, using AgNO 3 -impregnated silica gel chromatography. In addition, cafestol palmitate (3) and kahweol palmitate (4), the two natural diterpene esters of C. arabica, were also synthesized. Compounds 1-4 were evaluated for anti-inflammatory activity using cyclooxygenase-2 (COX-2), cell aggregation, cell proliferation, cell adhesion, iNOS and antioxidant assays. The COX-2 inhibitory activity of cafestol (1) was found to be 20-fold more potent than kahweol (2) (IC 50 value 0.25 μg/mL vs. 5.0 μg/mL), while compounds 3 and 4 were weakly active. The isolation and structure elucidation of the diterpenes 1 and 2, preparation of compounds 3 and 4, and their biological activities are presented in this paper.
OH 17 OR beverages [1] as esters, including cafestol and kahweol palmitates (3 and 4, respectively). Both 1 and 2 increase blood cholesterol level in humans and animals, and they are chemoprotective [2, 3] . However, animal studies have shown that kahweol and cafestol offer some protection against the action of well known carcinogens [4, 5] . In line with these observations, there is epidemiological evidence in humans that the consumption of coffee with a high amount of cafestol (1) and kahweol (2) is associated with a lower rate of colon cancer [6] .
The targeted inhibition of cyclooxygenase-2 (COX-2) activity is a promising approach for the discovery of anticancer and anti-inflammatory compounds. The enzyme cyclooxygenase exists in two isoforms COX-1 and COX-2. They catalyze the first step in the biosynthesis of prostaglandins, thromboxanes and prostacyclins. Traditional nonsteroidal antiinflammatory drugs (NSAIDs), such as aspirin and ibuprofen, inhibit both COX-1 and COX-2. The anti-inflammatory action of NSAIDs is due to the inhibition of COX-2, whereas the unwanted side effects, such as irritation of stomach lining, ulcers and toxic effects on kidney are due to the inhibition of COX-1. Finding COX-2 specific inhibitors has been the focus of attention for new and safe NSAID development. The isolation of 1 and 2, synthesis of the palmitate esters 3 and 4, and evaluation of anti-inflammatory and anticancer properties of compounds 1-4 (ie. inhibition of COX-2, cell aggregation, cell proliferation, cell adhesion, iNOS, ROS generation and cytotoxic activities) are discussed in this paper.
An examination of coffee oil extracted by CHCl 3 from C. arabica unroasted beans, showed weak COX-2 inhibitory activity.
The structures of 1 and 2 were determined by standard spectral methods, including NMR spectroscopy and mass spectrometry, and their identities were confirmed by direct comparison with authentic samples. The palmitic acid esters 3 and 4 were prepared from 1 and 2, respectively, in near 100% yield using palmitic acid and dicyclohexyl carbodiimide with catalytic amounts of 4-dimethylaminopyridine. The esters were identified by spectral data, including 13 C NMR spectroscopy (Table 1) . However, only the 13 C NMR spectral data of cafestol (1) has been reported previously [6]. Cafestol (1), kahweol (2) and palmitate esters 3 and 4 were evaluated for anti-inflammatory activity using our in-house COX-2, cell aggregation, cell proliferation, cell adhesion, iNOS and antioxidant assays [7] [8] [9] [10] . Cafestol (1) demonstrated potent activity against the COX-2 enzyme in LPS-induced macrophages (RAW 264.7), compared to those observed for kahweol (2) and palmitate esters 3 and 4 ( Table 2 ). The inhibitory activity of cafestol (1) was found to be 20-fold more potent than kahweol (2) (IC 50 values 0.25 μg/mL vs. 5 μg/mL), while their palmitates 3 and 4 were weakly active. In addition, no cytotoxicity was observed for compounds 1-4 against RAW 264.7 cells.
The inhibition of cell aggregation, cell adhesion, nitric oxide synthetase (iNOS) and antioxidant activity of cafestol (1) was found to be very weak compared to kahweol (2) ( Tables 3-5 ). However, the cell adhesion activity of kahweol palmitate (4) was similar to 2 (10 μg/mL), while cafestol (1) and its ester (3) were inactive, which suggested that cafestol might have very specific activity against COX-2 in comparison to kahweol. All compounds (1-4) were found to be non-toxic to mammalian VERO cells, as well as tumor cells (data not shown). The COX-2 activity of cafestol and kahweol was reported by Kim et al. (2004) , but only qualitatively [11] , and their structures were drawn erroneously, which showed kahweol (2) was more effective qualitatively than cafestol (1). However, our study suggested that cafestol was more potent than kahweol and palmitate esters 3 and 4.
In conclusion, the coffee-specific diterpenes, cafestol (1) and kahweol (2) were found to inhibit LPS induced COX-2 activity in the macrophages, while the two natural compounds of coffee bean, cafestol palmitate (3) and kahweol palmitate (4) 
Extraction and isolation:
The unroasted C. arabica powder (2 Kg) was extracted with CHCl 3 at RT (1 L x 3). The combined extract was evaporated under vacuum to give 470 g of coffee oil. To this oil, 300 mL of 5% KOH in MeOH was added and the mixture stirred for 2 h under N 2 at RT. After 2 h, the reaction mixture was diluted with n-hexane (750 mL) and then extracted with MeOH-H 2 O (9:1; 750 mL). The n-hexane phase, containing the fatty acid methyl esters, was then separated from the aqueous methanol phase, which contained esters of 1 and 2. The extraction was repeated twice, which gave 550 g extract. KOH (25 g) was dissolved in the concentrated extract (500 g) from the previous step and agitated at 40°C under N 2 for 30 min., then 1 L of water was added. This was extracted with 8% MeOH in CH 2 Cl 2 (900 mL x 5), and then the combined extract was evaporated to dryness, which gave 50 g of orangecolored oil (crude mixture 1 + 2). The oil (5 g) was subjected to CC over 10% AgNO 3 -impregnated silica gel, using 5% EtOAc-n-hexane as solvent, to afford cafestol (1; 0.8 g) and kahweol (2; 0.75 g). The identity of 1 and 2 was confirmed by direct comparison with authentic samples, as well as from physical (mp and OR) and spectral data (UV, IR, NMR and MS) published in the literature [7, 8] .
Cafestol (1) Colorless plates. MP: 160-161ºC. 13 (3 mL) and a catalytic amount of 4-dimethylaminopyridine was added to the solution. The reaction mixture was stirred in the dark at RT under N 2 for 20 min., dicyclohexylcarbodiimide (51.5 mg, 0.25 mmol) was added to the reaction mixture and stirred at the same temperature. Progress of the reaction was monitored by Si-gel TLC, and completed in 80 min. The solid dicyclohexyl urea was removed by filtration, the filtrate was dried under reduced pressure at 20 °C. The semi-solid mass was subjected to Si-gel CC (n-hexane / EtOAc, 1:1) to give the pure products 3 (49 mg) and 4 (94 mg), after purification.
Cafestol palmitate (3)
Colorless oil. 13 C NMR: Table 1 . The OR, IR, MS, 1 H and 13 C spectra were identical to those of an authentic sample.
Kahweol palmiate (4)
Cell based assay for inhibition of COX-2 activity:
Mouse macrophages (RAW 264.7, ATCC, USA)
were cultured in a 75 mL culture flask in RPMI-1640 medium (Gibco TM , Invitrogen Corp. USA), supplemented with 10% bovine calf serum (Hyclone) and 60 mg/L amikacin (Sigma), at 37ºC in an atmosphere of 95% humidity and 5% CO 2 . For the assay, cells were seeded in the wells of 96-well plates (50,000 cells/well) and incubated at 37ºC for 24 h. Confluent cells were treated with 250 µM aspirin for 30 min to completely inactivate COX-1 activity. After washing thoroughly with medium, the cells were incubated with 5 μg/mL LPS (Sigma) for 16 h to induce the production of COX-2. Induced cells were washed thoroughly with medium to remove LPS completely and treated with different concentrations of test samples for 2 h. Arachidonic acid (300 μM, Sigma) was added and the cells were incubated for a further 30 min. Supernatants were removed and the amount of PGE 2 released in the medium was determined using a PGE 2 Enzyme Immunoassay kit (Cayman Chem. Co., USA). COX-2 activity was determined based on the conversion of exogenous arachidonic acid to PGE 2 and is expressed as a % of the solvent control (DMSO, 0.5% highest). The IC 50 value is calculated from the dose curves generated by plotting % inhibition of COX-2 against the test concentrations. NS-398 (Cayman Chem. Co.), a specific inhibitor of COX-2, is included as a positive control in each assay.
Cell aggregation and XTT assays:
Effects on cell aggregation were determined as previously described [10] . HL-60, the myelomonocytic cell line, was suspended at a density of 1 x 10 6 cells/mL and 150 µL of the cell suspension was added to each well of a 96-well plate. After incubation of the test sample for 10 min, phorbol myristate acetate (PMA, 10 ng/mL) was added. Plates were placed in a CO 2 incubator and aggregation of the cells was observed microscopically 16 h after the PMA addition. The known cell aggregation inhibitor cytochalasin B, anti-LFA-1 and anti-ICAM-1 monoclonal antibody were used as positive controls. Following the cell aggregation assay, the XTT (3´-1[(phenylamino)carbonyl]-3,4-tetrazolium-bis(4-methoxy-6-nitro) benzene sulfonic acid hydrate) assay was performed [12, 13] Briefly, 25 µL of XTT-phenazine methosulfate (PMS) solution (1 mg/mL XTT solution supplemented with 25 µM of PMS) was added to the cells in each well of the microplates. After incubating for 4 h at 37°C, absorbance at 450 nm was measured by a microplate reader (reference absorbance at 630 nm). [12] : HL-60 cells were stained with CFSE (carboxyfluorescein diacetate succinimyl ester; Molecular Probes) [13] . CFSE labeled HL-60 cells and potential inhibitors were added to the wells of microplates that contained confluent monolayers. PMA was added to HeLa cells, a carcinoma cell line that expresses ICAM-1. A concentration of 50 ng/mL stimulates the HL-60 cells to convert LFA-1 to its high avidity binding state [14] . The cultures were incubated in a CO 2 incubator for 45 min at 37°C. Nonadherent HL-60 cells were washed off, the remaining cells were solubilized with 1% Triton X-100 and fluorescence was quantified using a CytoFluor 2350, Fluorescence Measurement System (Millipore), with an excitation wavelength of 496 nm and an emission one at 519 nm. Anti-ICAM-1 monoclonal antibody was used as a positive control. MTT assay for cytotoxicity of RAW264.7 cells [9] : RAW 264.7 cells (2 x 10 4 cells) in 225 µL were plated into a 96-well microplate. Four h after incubation, 25 µL of each sample solution was added to each well and the plate was re-incubated for 2 days. After cells were exposed to the test materials, 25 µL of MTT stock solution (5 mg/mL in PBS) was added to each well and the plate was incubated at 37°C for 4 h. After aspiration of the medium, 100 µL of 0.04 N HCl-isopropanol was added to each well and mixed for 20 min at room temperature; the plate was read on a microplate reader at 570 nm (reference wavelength 630 nm). [15, 16] : Inhibition of ROS generation: The effect of samples on the generation of ROS in myelomonocytic HL-60 cells was determined by the DCFH-DA (2',7'dichlorofluorescin diacetate) method (1). HL-60 cells (ATCC) were cultured in RPMI-1640 medium with 10% fetal bovine serum, penicillin (50 units/mL) and streptomycin (50 µg/mL). The cell suspension (125 µL containing 1x10 6 cells/mL) was added to the wells of a 96-well plate. After treatment with different concentrations of the test samples for 30 min, cells were exposed to 100 ng/mL phorbol 12-myristate-13acetate (PMA, Sigma) for 30 min. DCFH-DA (Molecular Probes, 5 μg/mL) was added and cells were further incubated for 15 min. Levels of fluorescent DCF (produced by ROS catalyzed oxidation of DCFH) was measured on a PolarStar Galaxy plate reader with an excitation wavelength of 485 nm and an emission wavelength of 530 nm. Inhibition of ROS generation by test samples was determined in terms of % decrease in DCF production compared to the vehicle control. Vitamin C and trolox were used as the positive control in each assay.
Cell adhesion assay

Determination of NO production:
Cell based assay for antioxidant activity
DCFH-DA is a non-fluorescent probe that diffuses into cells, where cytoplasmic esterases hydrolyse the DCFH-DA to 2',7'-dichlorofluorescin (DCFH). The ROS generated within HL-60 cells oxidize DCFH to the fluorescent dye 2',7'-dichlorofluorescein (DCF).
The ability of the test materials to inhibit exogenous cytoplasmic ROS-catalysed oxidation of DCFH in HL-60 cells is measured in comparison to PMA treated vehicle control.
The cytotoxicity of samples to HL-60 cells was also determined after incubating the cells (2 x 10 4 cells/well in 225 µL) with test samples for 48 h by the XTT method (2) . Briefly, 25 µL of XTT-PMS solution (1 mg/mL XTT solution supplemented with 25 µM of PMS) was added to each well. After incubating for 4 h at 37 o C, the absorbance was measured at a dual wavelength of 450 -630 nm on a Bio-Tek plate reader.
